518 related articles for article (PubMed ID: 26780455)
21. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
22. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
23. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
Wang D; Liu X; Liu Y; Li S; Wang C
J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
[TBL] [Abstract][Full Text] [Related]
25. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.
Oyegbami O; Collins HM; Pardon MC; Ebling FJP; Heery DM; Moran PM
Curr Alzheimer Res; 2017; 14(8):850-860. PubMed ID: 28317486
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
Raha AA; Henderson JW; Stott SR; Vuono R; Foscarin S; Friedland RP; Zaman SH; Raha-Chowdhury R
J Alzheimers Dis; 2017; 55(1):199-217. PubMed ID: 27662313
[TBL] [Abstract][Full Text] [Related]
27. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.
Ulrich JD; Finn MB; Wang Y; Shen A; Mahan TE; Jiang H; Stewart FR; Piccio L; Colonna M; Holtzman DM
Mol Neurodegener; 2014 Jun; 9():20. PubMed ID: 24893973
[TBL] [Abstract][Full Text] [Related]
28. Intracellular trafficking of TREM2 is regulated by presenilin 1.
Zhao Y; Li X; Huang T; Jiang LL; Tan Z; Zhang M; Cheng IH; Wang X; Bu G; Zhang YW; Wang Q; Xu H
Exp Mol Med; 2017 Dec; 49(12):e405. PubMed ID: 29611543
[TBL] [Abstract][Full Text] [Related]
29. Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice.
Metaxas A; Vaitheeswaran R; Jensen KT; Thygesen C; Ilkjaer L; Darvesh S; Finsen B
Curr Alzheimer Res; 2018 Mar; 15(5):420-428. PubMed ID: 28982335
[TBL] [Abstract][Full Text] [Related]
30. GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.
Liu C; Cheng ZY; Xia QP; Hu YH; Wang C; He L
Psychopharmacology (Berl); 2021 Aug; 238(8):2133-2146. PubMed ID: 34173034
[TBL] [Abstract][Full Text] [Related]
31. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
32. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
33. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
Bonardi C; de Pulford F; Jennings D; Pardon MC
Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
35. TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia.
Kim SM; Mun BR; Lee SJ; Joh Y; Lee HY; Ji KY; Choi HR; Lee EH; Kim EM; Jang JH; Song HW; Mook-Jung I; Choi WS; Kang HS
Sci Rep; 2017 Sep; 7(1):11118. PubMed ID: 28894284
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
Zhou Q; Wang M; Du Y; Zhang W; Bai M; Zhang Z; Li Z; Miao J
Ann Neurol; 2015 Apr; 77(4):637-54. PubMed ID: 25611954
[TBL] [Abstract][Full Text] [Related]
37. TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.
Zhao Y; Wu X; Li X; Jiang LL; Gui X; Liu Y; Sun Y; Zhu B; Piña-Crespo JC; Zhang M; Zhang N; Chen X; Bu G; An Z; Huang TY; Xu H
Neuron; 2018 Mar; 97(5):1023-1031.e7. PubMed ID: 29518356
[TBL] [Abstract][Full Text] [Related]
38. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.
Jiang T; Yu JT; Zhu XC; Tan MS; Gu LZ; Zhang YD; Tan L
Neurobiol Aging; 2014 Jun; 35(6):1243-51. PubMed ID: 24368090
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
[TBL] [Abstract][Full Text] [Related]
40. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.
Kajiwara Y; McKenzie A; Dorr N; Gama Sosa MA; Elder G; Schmeidler J; Dickstein DL; Bozdagi O; Zhang B; Buxbaum JD
Hum Mol Genet; 2016 Oct; 25(19):4315-4327. PubMed ID: 27516385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
